Alzheimers Disease
BMJ 338:467-471, Burns,A. &Iliffe,S., 2009
Assessment and Management of Behavioral and Psychological Symptoms of Dementia
BMJ 350:h369, Kales, H.C.,et al, 2015
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimers Disease
NEJM 355:1525-1538,1604, Schneider,L.S.,et al, 2006
Psychiatric Manifestations of Creutzfeldt-Jakob Disease: A 25-Year Analysis
J Neuropsychiatry Clin Neurosci 17:489-495, Wall,C.A.,et al, 2005
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
JAMA 288:1475-1483, Lyketsos,C.G.,et al, 2002
Treatment of Alzheimer's Disease
NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
Central Nervous System Reactions to Histamine-2 Receptor Blockers
Ann Int Med 114:1027-1034, Cantu,T.G.&Korck,J.S., 1991
The Psychiatric Symptoms of Alzheimer's Disease
J Am Geriatr Soc 36:7-12, Merriam,A.E.,et al, 1988
Clinicopathologic Conference, Psychotic Disorder Due to a General Medical Condition (postictal psychosis)
NEJM 391:2036-2046, Case 37-2024, 2024
Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022
Clinicopathologic Conference, Advanced AIDS Complicated by HSV-1 Encephalopathy. Basal-Cell Carcinoma. Kaposis Sarcoma.
NEJM 376:2580-2589, Case 20-2017, 2017
Kleine-Levin Syndrome in 120 Patients: Differential Diagnosis and Long Episodes
Ann Neurol 77:529-540, Lavault, S.,et al, 2015
Anti-DPPX Encephalitis,Pathogenic Effects of Antibodies on Gut and Brain Neurons
Neurol 85:890-897, Piepgras,J.,et al, 2015
Recognition and Management of Withdrawal Delirium
NEJM 371:2109-2113, Schuckit, M.A., 2014
Paediatric Autoimmune Encephalopathies: Clinical Features, Laboratory Investigations and Outcomes in Patients with or without Antibodies to known Central Nervous System Autoantigens
JNNP 84:748-755, Hacohen, Y.,et al, 2013
Clinicopathologic Conference, Methcathinone (Bath Salts) Intoxication
NEJM 369:2536-2545, Case 40-2013, 2013
Relapse Risk after Discontinuation of Risperidone in Alzheimers Disease
NEJM 367:1497-1507, Devanand, D.P.,et al, 2012
Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005
The Efficacy of Donepezil in the Treatment of Neuropsychiatric Symptoms in Alzheimer Disease
Neurol 63:214-219,200, Holmes,C.,et al, 2004
Potassium Channel Antibody-Associated Encephalopathy: A Potentially Immunotherapy-Responsive Form of Limbic Encepahlitis
Brain 127:701-712, Vincent,A.,et al, 2004
Alzheimer Disease
JAMA 287:2335-2338, Cummings,J.L. &Cole,G., 2002
Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000
Treatment of Agitation in AD
Neurol 55:1271-1278,1247, Teri,L.,et al, 2000
Central Anticholinergic Syndrome on Therapeutic Doses of Cyproheptadine
Pediatrics 103:158-160, Watemberg,N.M.,et al, 1999
An Algorithm (Decision Tree) for the Management of Parkinson's Disease:Trtm Guidelines
Neurol 50:S1-S57, Olanow,C.W.&Koller,W.C., 1998
Diagnosis and Treatment of Alzheimer Disease and Related Disorders
JAMA 278:1363-1371, Small,G.W.,et al, 1997
Psychiatric Features in Diffuse Lewy Body Disease:A Clinicopath Study Using Alzheimer's & PD Groups
Neurol 47:1148-1152, Klatka,L.A.,et al, 1996
Management of the Behavioral Manifestations of Dementia
Arch Int Med 155:250-260, Yeager,B.F.,et al, 1995
Anticholinergic Poisoning Associated with Herbal Tea
Arch Int Med 155:2245-2248, Hsu,C.K.,et al, 1995
Acute Neurologic & Psychiatric Complications Associated with Cocaine Abuse
Am J Med 83:841-846, Lowenstein,D.H.,et al, 1987
Acute Psychosis as Idiosyncratic Reaction to Quinidine:Report of Two Cases
BMJ 294:1001-1002, Deleu,D.&Schmedding,E., 1987
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Scopalamine Psychosis Revisited
Ann Neurol 13:582, Cairncross,J.G., 1983
Migraine Presenting as Acute Confusion & Delirium:A Case Report
Neurol 28:1201, Finelli,P.F., 1978
Neurologic Disorders in Renal Failure (1st of Two Parts)
NEJM 294:143, Raskin,N.H.,et al, 1976
Clinical Use and Toxicity of Intravenous Lidocaine, A Report from the Boston Collaborative Drug Surveillance Program
Am Heart J 92:168-173, Pfeifer,H.J.,et al, 1976
Complicated Migraine
In Handbook of Clinical Neuro. , Ed. Vinken & Bruyn-5:Chap 6 N. Holland Pub. Co., Bruyn,G.W., 1968
Chronic Neuropsychiatric Sequelae Associated with Kambo Intoxication
JAMA Neurol 82:418-419, Jauregui,R.,et al, 2025
Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimers Disease
JAMA Neurol 80:1272-1273, Ballard,C., 2023
Clinicopathologic Conference, Delayed Postthypoxic Leukoencephalopathy
NEJM 384:2438-2445, Case 19-2021, 2021
Sporadic Creutzfeldt-Jakob Disease in a Very Young Person
Neurol 97:813-816,801, Appleby, B.S.,et al, 2021
An unusual neuropsychiatric manifestation of systemic lupus erythematosus
Neurol 90:e1929-e1932, Dongkyung, D.,et al, 2018
Clinicopathologic Conference, Poststroke Mania and the Frontal Lobe Syndrome
NEJM 379:182-189, Case 21-2018, 2018
Clinicopathological Conference, Insulinoma
NEJM 379:376-384, Case 23-2018, 2018
Neurocutaneous Melanosis with Diffuse Leptomeningeal Malignant Melanoma in an Adult
Neurol 86:e75-e79, Bhatia, R.,et al, 2016
Human Neurexin-3a Antibodies Associate with Encephalitis and Alter Synapse Development
Neurol 86:2235-2242,2222, Gresa-Arribas, N.,et al, 2016
"Noncognitive" Symptoms of Early Alzheimer Disease
Neurol 84:617-622, Masters, M.C.,et al, 2015
Clinicopathologic Conference, Ethylene Glycol Ingestion
NEJM 372:465-473, Case 4-2015, 2015